Enfamil maker Reckitt sees formula shortage continuing until Spring

[December 01, 2022]  By Richa Naidu

LONDON (Reuters) - A shortage of infant formula that has hit the United States for most of this year - prompting White House intervention - is likely to "persist to some degree" until spring, according to the maker of Enfamil, now the biggest brand in the market.

"I don't think they're entirely back to normal," said Robert Cleveland, Reckitt Benckiser's senior vice president, North America and Europe Nutrition, told Reuters in an interview. "Some retailers still look better than others, some product lines still look better than others."

Mead Johnson's product Enfamil baby formula are displayed on a store shelf in New York City, U.S., February 10, 2017. REUTERS/Brendan McDermid

(Reporting by Richa Naidu in London. Additional reporting by Jessica DiNapoli in New York; Editing by Matt Scuffham)

[© 2022 Thomson Reuters. All rights reserved.]  This material may not be published, broadcast, rewritten or redistributed.  Thompson Reuters is solely responsible for this content.